The CAS registry number of Phleomycin is 11006-33-0. The systematic name is 2'-{5-acetyl-15-(6-amino-2-{3-amino-1-[(2,3-diamino-3-oxopropyl)amino]-3-oxopropyl}-5-methylpyrimidin-4-yl)-13-[{[(2R,3S,4S,5S,6S)-3-{[(2S,3R,4R,5S)-4-carbamoyl-3,4,5-trihydroxy-6-(hydroxymethyl)tetra hydro-2H-pyran-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)-3-methyltetrahydro-2H-pyran-2-yl]oxy}(1H-imidazol-5-yl)methyl]-9-hydroxy-8,10-dimethyl-4,7,12,15-tetraoxo-3,6,11,14-tetraazapentadec-1-yl}-4',5 '-dihydro-2,4'-bi-1,3-thiazole-4-carboxamide. In addition, the molecular formula is C51H75N17O21S2 and the molecular weight is 1326.37. What's more, it belongs to the classes of Antibiotics; Antibiotics by Application; Antibiotics N-S Antibiotics; Chemical Structure Class; Genetic Marker Selection Antibiotics; Glycopeptides Antibiotics; Interferes with DNA SynthesisSpectrum of Activity; Mechanism of Action. And the storage temperature of this chemical is 2-8°C.
Physical properties about this chemical are: (1)ACD/LogP: -2.73; (2)# of Rule of 5 Violations: 3; (3)ACD/LogD (pH 5.5): -4.46; (4)ACD/LogD (pH 7.4): -2.9; (5)ACD/BCF (pH 5.5): 1; (6)ACD/BCF (pH 7.4): 1; (7)ACD/KOC (pH 5.5): 1; (8)ACD/KOC (pH 7.4): 1; (9)#H bond acceptors: 38; (10)#H bond donors: 26; (11)#Freely Rotating Bonds: 40; (12)Polar Surface Area: 422.42 Å2; (13)Index of Refraction: 1.777; (14)Molar Refractivity: 303.19 cm3; (15)Molar Volume: 724.4 cm3; (16)Polarizability: 120.19 ×10-24cm3; (17)Surface Tension: 88 dyne/cm; (18)Density: 1.83 g/cm3; (19)Flash Point: 993.3 °C; (20)Enthalpy of Vaporization: 286.59 kJ/mol; (21)Boiling Point: 1718.8 °C at 760 mmHg.
When you are using this chemical, please be cautious about it as the following:
This chemical is harmful if swallowed and irritating to eyes, respiratory system and skin. Whenever you will contact it, please wear suitable protective clothing. In case of contact with eyes, you should rinse immediately with plenty of water and seek medical advice.
You can still convert the following datas into molecular structure:
(1)SMILES: O=C(N)C(N)CNC(c1nc(N)c(c(n1)C(=O)NC(C(=O)NC(C)C(O)C(C(=O)NC(C(=O)C)C(=O)NCCC/3=N/C(c2scc(n2)C(=O)N)CS\3)C)C(O[C@@H]5O[C@@H](CO)[C@@H](O)[C@H](O)[C@@]5(O[C@@H]4OC(CO)[C@H](O)[C@](O)(C(=O)N)[C@H]4O)C)c6 cncn6)C)CC(=O)N
(2)InChI: InChI=1/C51H75N17O21S2/c1-16-29(65-41(68-38(16)54)21(8-27(53)72)60-9-20(52)39(55)78)44(82)67-31(34(22-10-58-15-61-22)88-49-50(5,36(76)33(74)25(11-69)87-49)89-47-37(77)51(85,48(57)84)35(75)26(12-70)86-47)45(83)62-18(3)32(73)17(2)42(80)66-30(19(4)71)43(81)59-7-6-28-63-24(14-90-28)46-64-23(13-91-46)40(56)79/h10,13,15,17-18,20-21,24-26,30-37,47,49,60,69-70,73-77,85H,6-9,11-12,14,52H2,1-5H3,(H2,53,72)(H2,55,78)(H2,56,79)(H2,57,84)(H,58,61)(H,59,81)(H,62,83)(H,66,80)(H,67,82)(H2,54,65,68)/t17?,18?,20?,21?,24?,25-,26?,30?,31?,32?,33+,34?,35-,36-,37-,47-,49-,50-,51+/m0/s1
(3)InChIKey: QRBLKGHRWFGINE-UGWAGOLRBV
The toxicity data is as follows:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
dog | LD50 | intravenous | 2500ug/kg (2.5mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: DYSPNEA | Toxicology and Applied Pharmacology. Vol. 14, Pg. 590, 1969. |
guinea pig | LDLo | intravenous | 13mg/kg (13mg/kg) | Journal of Antibiotics, Series A. Vol. 19, Pg. 260, 1966. | |
mouse | LD50 | intraperitoneal | 13mg/kg (13mg/kg) | Journal of Antibiotics, Series A. Vol. 19, Pg. 260, 1966. | |
mouse | LD50 | intravenous | 21mg/kg (21mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) LUNGS, THORAX, OR RESPIRATION: DYSPNEA BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Toxicology and Applied Pharmacology. Vol. 14, Pg. 590, 1969. |
mouse | LD50 | oral | 371mg/kg (371mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: DYSPNEA | Toxicology and Applied Pharmacology. Vol. 14, Pg. 590, 1969. |
mouse | LD50 | subcutaneous | 25mg/kg (25mg/kg) | Journal of Antibiotics, Series A. Vol. 19, Pg. 260, 1966. | |
rat | LD50 | intravenous | 4mg/kg (4mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: DYSPNEA | Toxicology and Applied Pharmacology. Vol. 14, Pg. 590, 1969. |
rat | LD50 | oral | 649mg/kg (649mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: DYSPNEA | Toxicology and Applied Pharmacology. Vol. 14, Pg. 590, 1969. |
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View